Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.38 |
| ▸ | MEN1 | O00255 | 7/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.38 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976219 | 0.88 | MAPT (0.50) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL13326515 | 0.88 | MAPT (0.50) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL30612732 | 0.88 | MAPT (0.50) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL29473569 | 0.88 | MAPT (0.50) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL8680277 | 0.88 | MAPT (0.40) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL1300804 | 0.88 | SMN1; SMN2 (0.37) | MAPTMEN1KMT2ALMNANPSR1 | |
| SCHEMBL8680346 | 0.88 | MAPT (0.39) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL8680358 | 0.87 | SMN1; SMN2 (0.47) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL29624244 | 0.85 | KMT2A (0.39) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL8680539 | 0.85 | MAPT (0.46) | MAPTMEN1KMT2ALMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| US-20110269242-A1 | TIME TEMPERATURE INDICATOR COMPRISING INDOLENIN BASED SPIROPYRANS | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20100034961-A1 | PHOTOSTABILIZED TIME TEMPERATURE INDICATOR | FRESHPOINT HOLDINGS SA (CH) | 2010-02-11 | — | — | US | disclosed |
| US-20100034961-A1 | PHOTOSTABILIZED TIME TEMPERATURE INDICATOR | FRESHPOINT HOLDINGS SA (CH) | 2010-02-11 | — | — | US | disclosed |
| WO-2008083925-A1 | PHOTOSTABILIZED TIME TEMPERATURE INDICATOR | FRESHPOINT HOLDINGS SA (CH) | 2008-07-17 | — | — | WO | disclosed |
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5710420-A | Method for embedding and recovering machine-readable information | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| US-5633109-A | Ink compositions with liposomes containing photochromic compounds | XEROX CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| US-3999989-A | SALTS OF INDOLINE SPIROBENZOPYRANS | FUJI PHOTO FILM CO., LTD. (JA) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269242-A1 | TIME TEMPERATURE INDICATOR COMPRISING INDOLENIN BASED SPIROPYRANS | TTN, CCNI, TPH1 | MAPT 90/4885MEN1 2519/4885KMT2A 1072/4885 |
| US-20100034961-A1 | PHOTOSTABILIZED TIME TEMPERATURE INDICATOR | TTI1, NQO2, CCNI | MAPT 3732/4885MEN1 828/4885KMT2A 4254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.